Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (£272m) over five years due to Washington's request for confidential biological samples.
This rejection was revealed following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesperson has since stated that the US was demanding access to biological samples for scientific study and commercial gain but was unwilling to share the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further dialogue to find a agreement suitable to all parties so the nation's vital HIV programme can continue.
Wider Implications
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were raised about the safety of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our citizens if a future pandemic emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting frameworks already established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This framework is intended to guarantee that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued discussions with our American counterparts on how future collaboration could be structured in a way that respects the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations need to persist since much of the nation's HIV programmes relied on international support.
"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," it commented.
This impasse emphasises the ongoing debate between accepting much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.